[PAPRICA-2 study: Role of precipitating factor of an XXXX episode on intermediate term prognosis].

@entity1 @entity1187 @entity712 @entity417 @entity101 @entity4059 @entity281 @entity955
OBJECTIVE: To evaluate the @entity4059 ( @entity4059 ) associated with @entity712 and their association with medium-term prognosis. @entity1 AND METHODS: Multipurpose prospective study from the EAHFE Registry. We included as @entity4059 : @entity281 , @entity955 ( @entity955 ), @entity417 , @entity101 crisis, non-adherence to diet or drug therapy and non-ST-segment-elevation @entity1187 (NSTEACS). @entity1 without @entity4059 were control group. Hazard ratios (HR) crudes and adjusted for reconsultations and mortality at 90 days were calculated. RESULTS: 3535 @entity1 were included: 28% without and 72% with @entity4059 . @entity1 with @entity955 (HR 0.67; 95%CI 0.50-0.89) and @entity101 crisis (HR 0.45; 95%CI 0.28-0.72) had less mortality and @entity1 with NSTEACS (HR 1.79; 95%CI 1.19-2.70) had more mortality. Reconsultation was fewer in @entity1 with @entity281 (HR 0.74; 95%CI 0.64-0.85), @entity955 (HR 0.69; 95%CI 0.58-0.83) and @entity101 crisis (HR 0.71; 95%CI 0.55-0.91). These differences were maintained in all the adjusted models except for @entity101 crisis. CONCLUSIONS: One @entity4059 is identified in 3 out of 4 @entity1 and it may influence medium-term prognosis. At 90 days, NSTEACS and @entity955 were associated with more and less mortality respectively, and @entity955 and @entity281 with less probability of reconsultation.
